1,0
2 sep 2024
Huidige werknemer, meer dan 5 jaar
Barcelona
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht
Pluspunten
Interactions with FDA, EMA and local agencies at the Regulatory Department
Minpunten
In the Clinical Development Dpt, employees without elemental medical and scientific knowledge, lack of GCP rules during the trial execution, many problems with many "interpretations" of study protocol and data leading to very poor results